The inaugural edition of Premier Voices focuses on rare oncology drug development and takes a looks at:
- Using adaptive design to limit patient exposure to ineffective treatments and increase the overall likelihood of success
- Making the most of small and geographically dispersed patient populations
- Dealing with limitations such as a lack of defined biomarkers and baseline standard-of-care therapies
- Finding out what Dr. Colin Hayward, our chief medical officer, would be doing if he weren’t working in clinical development!
Full presentation: https://premier-research.com/from-laboratory-to-bedside-expediting-development-of-novel-rare-cancer-treatments/
Where to find us: premier-research.com/events/